Insulin glargine and lixisenatide Subcutaneous and Zemplar Injection
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Zemplar Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: paricalcitol
Brand name: Zemplar
Synonyms: Paricalcitol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Zemplar Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Zemuron
- Insulin glargine and lixisenatide Subcutaneous-Zenapax
- Insulin glargine and lixisenatide Subcutaneous-Zenatane
- Insulin glargine and lixisenatide Subcutaneous-Zenchent
- Insulin glargine and lixisenatide Subcutaneous-Zenchent birth control
- Zemplar Injection-Insulin glargine, recombinant Subcutaneous
- Zemplar Injection-Insulin glulisine
- Zemplar Injection-Insulin Glulisine (Cartridges and Pens)
- Zemplar Injection-Insulin Glulisine (Vials)
- Zemplar Injection-Insulin glulisine Subcutaneous
- Zemplar Injection-Insulin human inhaled Inhalation